<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31619967</article-id>
<article-id pub-id-type="pmc">6759510</article-id>
<article-id pub-id-type="doi">10.3389/fncel.2019.00424</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to Autism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Araujo</surname>
<given-names>Daniel John</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tjoa</surname>
<given-names>Karensa</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/756522/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saijo</surname>
<given-names>Kaoru</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/755180/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Molecular &amp; Cell Biology, University of California</institution>, <addr-line>Berkeley, Berkeley, CA</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Helen Wills Neuroscience Institute, University of California</institution>, <addr-line>Berkeley, Berkeley, CA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Yu Tang, Central South University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Carmen Guaza, Cajal Institute (CSIC), Spain; Nagarkatti Prakash, University of South Carolina, United States; Raphael Mechoulam, The Hebrew University of Jerusalem, Israel</p>
</fn>
<corresp id="c001">*Correspondence: Kaoru Saijo, <email>ksaijo@berkeley.edu</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Cellular Neurophysiology, a section of the journal Frontiers in Cellular Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>13</volume>
<elocation-id>424</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Araujo, Tjoa and Saijo.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Araujo, Tjoa and Saijo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Microglia are the resident, innate immune cells of the central nervous system (CNS) and are critical in managing CNS injuries and infections. Microglia also maintain CNS homeostasis by influencing neuronal development, viability, and function. However, aberrant microglial activity and phenotypes are associated with CNS pathology, including autism spectrum disorder (ASD). Thus, improving our knowledge of microglial regulation could provide insights into the maintenance of CNS homeostasis as well as the prevention and treatment of ASD. Control of microglial activity is in part overseen by small, lipid-derived molecules known as endogenous cannabinoids (endocannabinoids). Endocannabinoids are one component of the endocannabinoid system (ECS), which also includes the enzymes that metabolize these ligands, in addition to cannabinoid receptor 1 (CB<sub>1</sub>) and 2 (CB<sub>2</sub>). Interestingly, increased ECS signaling leads to an anti-inflammatory, neuroprotective phenotype in microglia. Here, we review the literature and propose that ECS signaling represents a largely untapped area for understanding microglial biology and its relationship to ASD, with special attention paid to issues surrounding the use of recreational cannabis (marijuana). We also discuss major questions within the field and suggest directions for future research.</p>
</abstract>
<kwd-group>
<kwd>microglia</kwd>
<kwd>endocannabinoids</kwd>
<kwd>autism</kwd>
<kwd>neuroinflammation</kwd>
<kwd>neurodevelopment</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="97"></ref-count>
<page-count count="7"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Microglia represent a self-sustaining population of cells that originates from the yolk sac and colonizes the brain <italic>in utero</italic> (<xref ref-type="bibr" rid="B2">Alliot et al., 1999</xref>; <xref ref-type="bibr" rid="B31">Ginhoux et al., 2010</xref>; <xref ref-type="bibr" rid="B13">Bruttger et al., 2015</xref>; <xref ref-type="bibr" rid="B5">Askew et al., 2017</xref>; <xref ref-type="bibr" rid="B35">Huang et al., 2018</xref>). Microglia are the resident immune cells of the central nervous system (CNS) and thus are the first line of defense against CNS infection and injury. For example, they phagocytize debris and pathogens as well as initiate neuroinflammatory responses through release of cytokines such as interleukin-1 (IL-1), IL-6, and tumor necrosis factor alpha (TNF-α) (<xref ref-type="bibr" rid="B93">Yang et al., 2010</xref>; <xref ref-type="bibr" rid="B39">Janda et al., 2018</xref>). They also recruit natural killer cells, macrophages, and lymphocytes to sites of infection and injury (<xref ref-type="bibr" rid="B93">Yang et al., 2010</xref>). Moreover, microglia influence the health of their local environment through release of neurotrophic and neurotoxic factors (<xref ref-type="bibr" rid="B58">Nakajima et al., 2001</xref>; <xref ref-type="bibr" rid="B82">Srinivasan et al., 2004</xref>; <xref ref-type="bibr" rid="B63">Parkhurst et al., 2013</xref>).</p>
<p>In addition to the aforementioned roles, microglia carry out other functions essential for CNS homeostasis (<xref ref-type="bibr" rid="B72">Saijo and Glass, 2011</xref>; <xref ref-type="bibr" rid="B14">Butovsky and Weiner, 2018</xref>; <xref ref-type="bibr" rid="B45">Lenz and Nelson, 2018</xref>). Specifically, these cells oversee neurogenesis by both phagocytizing and directing the migration of newborn neurons (<xref ref-type="bibr" rid="B81">Sierra et al., 2010</xref>; <xref ref-type="bibr" rid="B70">Ribeiro Xavier et al., 2015</xref>). Microglia also regulate neuronal connections by engulfing excessive synaptic structures through use of the classical complement cascade (<xref ref-type="bibr" rid="B85">Stevens et al., 2007</xref>). Lastly, microglia modulate neuronal plasticity via release of neurotrophins such as brain-derived neurotrophic factor (BDNF) (<xref ref-type="bibr" rid="B63">Parkhurst et al., 2013</xref>). Early wiring of the brain requires tight control of these processes and therefore microglia critically impact CNS development (<xref ref-type="bibr" rid="B61">Paolicelli et al., 2011</xref>; <xref ref-type="bibr" rid="B11">Bialas and Stevens, 2013</xref>; <xref ref-type="bibr" rid="B80">Shigemoto-Mogami et al., 2014</xref>).</p>
<p>Due to their wide-ranging contributions to CNS homeostasis and development, microglia displaying irregular activity and/or phenotypes can lead to disorders of the CNS (<xref ref-type="bibr" rid="B74">Salter and Stevens, 2017</xref>; <xref ref-type="bibr" rid="B14">Butovsky and Weiner, 2018</xref>). In this review, we focus on microglial dysfunction as it relates to autism spectrum disorder and associated conditions. We also discuss the role of the endogenous cannabinoid system in modulating microglial involvement in these disorders.</p>
</sec>
<sec id="S2">
<title>Microglia and Autism Spectrum Disorder</title>
<p>The Autism and Developmental Disabilities Monitoring Network estimates the current prevalence of autism spectrum disorder (ASD) to be 1 in 59 among children in the United States (<xref ref-type="bibr" rid="B7">Baio et al., 2018</xref>). ASD denotes a collection of heterogeneous neurodevelopmental disorders defined by (1) repetitive, restricted behaviors and interests and (2) abnormalities in socio-communication (<xref ref-type="bibr" rid="B3">American Psychiatry Association, 2013</xref>). Thus, ASD is an umbrella term and it encompasses several disorders including autism, Asperger’s syndrome, pervasive developmental disorder not otherwise specified, and childhood disintegrative disorder (<xref ref-type="bibr" rid="B3">American Psychiatry Association, 2013</xref>). Conditions frequently comorbid with ASD include intellectual disability, attention-deficit/hyperactivity disorder, epilepsy, perturbed sleep patterns, aggression, anxiety, and altered sensory perception (<xref ref-type="bibr" rid="B44">Leitner, 2014</xref>; <xref ref-type="bibr" rid="B83">Srivastava and Schwartz, 2014</xref>; <xref ref-type="bibr" rid="B29">Fakhoury, 2015</xref>; <xref ref-type="bibr" rid="B62">Park et al., 2016</xref>; <xref ref-type="bibr" rid="B67">Postorino et al., 2016</xref>). These associated conditions can vary in severity and be more or less common within patient subsets. Finally, due to the lack of available therapeutics for ASD, there is a continuous, pressing need for investigation into the causes and progression of the disorder.</p>
<p>Given their role in CNS development and neuroinflammation, microglia are poised to influence the pathogenesis of ASD (<xref ref-type="bibr" rid="B25">Edmonson et al., 2016</xref>; <xref ref-type="bibr" rid="B74">Salter and Stevens, 2017</xref>; <xref ref-type="bibr" rid="B45">Lenz and Nelson, 2018</xref>). Evidence for microglial involvement in ASD comes from both post-mortem- and positron-emission tomography (PET)-imaging studies which show increased neuroinflammation and numbers of activated microglia in brains of ASD patients (<xref ref-type="bibr" rid="B88">Vargas et al., 2005</xref>; <xref ref-type="bibr" rid="B55">Morgan et al., 2010</xref>; <xref ref-type="bibr" rid="B86">Suzuki et al., 2013</xref>). More recently, a large-scale analysis of transcriptomic datasets from post-mortem cerebral cortex has revealed a distinct microglial signature in ASD brains (<xref ref-type="bibr" rid="B30">Gandal et al., 2018</xref>). This is concordant with previous observations of microglial activation-related gene enrichment in ASD brain-derived gene networks (<xref ref-type="bibr" rid="B89">Voineagu et al., 2011</xref>).</p>
<p>Altered synaptic density is observed in post-mortem ASD brain tissue (<xref ref-type="bibr" rid="B36">Hutsler and Zhang, 2010</xref>) and ASD mouse models (<xref ref-type="bibr" rid="B19">Comery et al., 1997</xref>; <xref ref-type="bibr" rid="B87">Tang et al., 2014</xref>; <xref ref-type="bibr" rid="B90">Wang et al., 2017</xref>). These alterations are presumably due to deficits in developmental synaptic pruning (<xref ref-type="bibr" rid="B34">Hansel, 2019</xref>). Indeed, current thinking posits that microglia can exert control over the progression of ASD through synaptic pruning dysregulation (<xref ref-type="bibr" rid="B22">Di Marco et al., 2016</xref>; <xref ref-type="bibr" rid="B45">Lenz and Nelson, 2018</xref>). This hypothesis is supported by the finding that inhibiting microglial autophagy leads to increased synaptic density and reduced sociability in mice (<xref ref-type="bibr" rid="B42">Kim et al., 2017</xref>). Moreover, mice with loss of microglia-enriched fractalkine receptor CX3C-chemokine receptor 1 (CX3CR1) display impaired synaptic pruning and reduced social interactions (<xref ref-type="bibr" rid="B94">Zhan et al., 2014</xref>). Additional support for the involvement of microglia in ASD pathogenesis comes from studies on mouse models of Rett syndrome (RTT), a syndromic form of ASD caused by mutations in the gene encoding methyl-CpG binding protein 2 (MECP2) (<xref ref-type="bibr" rid="B47">Lombardi et al., 2015</xref>). In one model of RTT, neuronal, but not microglial, loss of <italic>Mecp2</italic> leads to excessive synaptic engulfment by microglia in later stages of the disease (<xref ref-type="bibr" rid="B76">Schafer et al., 2016</xref>). This suggests that neuronal loss of MECP2 is sufficient to induce aberrant microglial activity and it is consistent with the observation that deletion of <italic>Mecp2</italic> using a <italic>Cx3cr1</italic>-Cre line does not produce RTT-like symptoms (<xref ref-type="bibr" rid="B91">Wolf et al., 2017</xref>). Furthermore, <italic>Mecp2-</italic>null microglia produce toxic levels of glutamate that damage post-synaptic structures <italic>in vitro</italic> (<xref ref-type="bibr" rid="B50">Maezawa and Jin, 2010</xref>). Still, due to the phenotypic and genetic heterogeneity of ASD, it remains to be seen if these findings in RTT models are representative of autism etiology in general.</p>
<p>Finally, children born to mothers who experience infections or autoimmune disease during their pregnancies are more likely to develop ASD (<xref ref-type="bibr" rid="B40">Jiang et al., 2016</xref>; <xref ref-type="bibr" rid="B15">Careaga et al., 2017</xref>). This phenomenon, known as maternal immune activation (MIA), has been phenocopied in rodent models (<xref ref-type="bibr" rid="B79">Shi et al., 2003</xref>; <xref ref-type="bibr" rid="B65">Patterson, 2011</xref>; <xref ref-type="bibr" rid="B15">Careaga et al., 2017</xref>; <xref ref-type="bibr" rid="B74">Salter and Stevens, 2017</xref>). While embryonic microglia may mediate the neuroinflammatory consequences of MIA (<xref ref-type="bibr" rid="B74">Salter and Stevens, 2017</xref>), how this underlies ASD remains unclear.</p>
<p>Considered together, the aforementioned findings implicate microglia as targets for the treatment of ASD. Due to its anti-inflammatory effects, the endogenous cannabinoid (endocannabinoid) system represents a promising tool for modulating microglial involvement in ASD. We next provide a brief overview of the endocannabinoid system and then summarize the evidence linking microglial-endocannabinoid signaling to ASD, with attention paid to issues surrounding the use of recreational cannabis.</p>
</sec>
<sec id="S3">
<title>The Architecture of the Endocannabinoid System</title>
<p>The endocannabinoid system (ECS) exerts control over microglial activity and therefore shows promise for treating CNS dysfunction (<xref ref-type="bibr" rid="B10">Benito et al., 2008</xref>; <xref ref-type="bibr" rid="B84">Stella, 2009</xref>; <xref ref-type="bibr" rid="B46">Lisboa et al., 2016</xref>). The ECS consists of three major components: (1) small, lipid-derived endocannabinoids (eCBs), (2) the enzymes responsible for synthesizing and degrading eCBs, and (3) the metabotropic receptors that recognize eCBs (<xref ref-type="bibr" rid="B49">Lutz et al., 2015</xref>). The most well-known eCBs in the brain are <italic>N</italic>-arachidonoylethanolamine (AEA or anandamide) and 2-arachidonoylglycerol (2-AG) (<xref ref-type="bibr" rid="B49">Lutz et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Parsons and Hurd, 2015</xref>). In response to increased cytoplasmic calcium, 2-AG and AEA are synthesized on demand from lipid precursors by the enzymes diacylglycerol lipase (DAGL) and <italic>N</italic>-acyl-phosphatidylethanolamine phospholipase D (NAPE-PLD), respectively (<xref ref-type="bibr" rid="B1">Alger and Kim, 2011</xref>; <xref ref-type="bibr" rid="B49">Lutz et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Parsons and Hurd, 2015</xref>). The enzyme primarily responsible for degrading 2-AG is monoacylglycerol lipase (MAGL), whereas AEA is catabolized by fatty acid amide hydrolase (FAAH). In the CNS, these components are expressed in neurons, microglia, astrocytes, and oligodendrocytes (<xref ref-type="fig" rid="F1">Figure 1</xref>; <xref ref-type="bibr" rid="B84">Stella, 2009</xref>; <xref ref-type="bibr" rid="B49">Lutz et al., 2015</xref>; <xref ref-type="bibr" rid="B37">Ilyasov et al., 2018</xref>). The two main receptors for eCBs include cannabinoid receptors 1 (CB<sub>1</sub>) and 2 (CB<sub>2</sub>), both of which are G protein-coupled (<xref ref-type="bibr" rid="B64">Parsons and Hurd, 2015</xref>). Finally, while CB<sub>1</sub> is enriched in neurons, CB<sub>2</sub> expression is primarily restricted to microglia (<xref ref-type="bibr" rid="B84">Stella, 2009</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The Components of the Endogenous Cannabinoid System in Microglia and Neurons. In the central nervous system (CNS), the endogenous cannabinoids (eCBs) <italic>N</italic>-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG) are the most widely-recognized ligands of the endogenous cannabinoid (endocannabinoid) system (ECS). The two main receptors for eCBs are cannabinoid receptor 1 (CB<sub>1</sub>) and cannabinoid receptor 2 (CB<sub>2</sub>), both of which are G-protein coupled. Within the CNS, eCB signaling is classically understood to modulate synaptic activity. In the example given here, release of glutamate from presynaptic neurons activates <italic>N</italic>-methyl-<sc>D</sc>-aspartate receptors (NMDARs) in postsynaptic neurons. In response to increased cytoplasmic calcium, the enzyme diacylglycerol lipase (DAGL) catalyzes the synthesis of 2-AG from diacylgylcerol (DAG) and <italic>N</italic>-acyl-phosphatidylethanolamine phospholipase D (NAPE-PLD) catalyzes the synthesis of AEA from the precursor <italic>N</italic>-acylphosphatidylethanolamine (NAPE). After 2-AG and AEA are released into the synaptic cleft, they stimulate CB<sub>1</sub> receptors on presynaptic neurons and inhibit further neurotransmitter release. 2-AG is mainly degraded by the enzyme monoacylglycerol lipase (MAGL) whereas AEA is degraded by fatty-acid amide hydrolase (FAAH). While DAGL, NAPE-PLD, MAGL, and FAAH are expressed broadly throughout the CNS, CB<sub>1</sub> is enriched in neurons and CB<sub>2</sub> is enriched in microglia. Stimulation of CB<sub>2</sub> leads to a protective phenotype in microglia that is characterized by a reduction in the release of pro-inflammatory cytokines such as interleukin-1 (IL-1).</p>
</caption>
<graphic xlink:href="fncel-13-00424-g001"></graphic>
</fig>
<p>Acute consumption of <italic>Cannabis sativa</italic> (marijuana) yields wide-ranging effects on memory, cognition, appetite, and mood in both humans and rodents (<xref ref-type="bibr" rid="B20">Curran et al., 2016</xref>; <xref ref-type="bibr" rid="B41">Kendall and Yudowski, 2016</xref>). These effects result from action of the phytocannabinoid (or plant-derived cannabinoid) Δ <sup>9</sup>-tetrahydrocannabinol (THC) on CB<sub>1</sub> within the brain (<xref ref-type="bibr" rid="B60">Panagis et al., 2014</xref>; <xref ref-type="bibr" rid="B20">Curran et al., 2016</xref>; <xref ref-type="bibr" rid="B41">Kendall and Yudowski, 2016</xref>). Yet, long-term consequences of cannabis use have been poorly studied, especially with regards to microglia and their impact on neuronal circuitry. Notably, increased eCB signaling is associated with an anti-inflammatory, protective phenotype in microglia (<xref ref-type="bibr" rid="B10">Benito et al., 2008</xref>; <xref ref-type="bibr" rid="B84">Stella, 2009</xref>; <xref ref-type="bibr" rid="B46">Lisboa et al., 2016</xref>). For example, pharmacological inhibition of FAAH decreases microglial activation marker expression, cytokine production, and synaptic plasticity deficits, in the hippocampi of aged rats (<xref ref-type="bibr" rid="B57">Murphy et al., 2012</xref>). Additionally, stimulation of CB<sub>2</sub> inhibits microglial activation and increases striatal neuron survival and motor coordination in a model of Huntington’s disease excitotoxicity (<xref ref-type="bibr" rid="B59">Palazuelos et al., 2009</xref>). Moreover, exposure to anti-inflammatory cytokines increases eCB production and CB<sub>2</sub> expression in microglia (<xref ref-type="bibr" rid="B53">Mecha et al., 2015</xref>). These findings cast the ECS as an attractive target for influencing microglial activity (<xref ref-type="bibr" rid="B21">Dhopeshwarkar and Mackie, 2014</xref>; <xref ref-type="bibr" rid="B46">Lisboa et al., 2016</xref>; <xref ref-type="bibr" rid="B16">Cassano et al., 2017</xref>; <xref ref-type="bibr" rid="B24">Donvito et al., 2018</xref>). However, the consequences of manipulating eCB signaling on ASD risk and pathogenesis are largely uncharacterized. The increasing legality and use of cannabis currently seen throughout the world therefore requires a better understanding of eCB signaling in microglia as it relates to ASD.</p>
</sec>
<sec id="S4">
<title>Microglial-Endocannabinoid Signaling and ASD</title>
<sec id="S4.SS1">
<title>Cannabis Use and ASD Risk</title>
<p>Approximately 2.5–5% of people between the ages of 15–64 years old consume cannabis, making it the most popular illicit drug in the world (<xref ref-type="bibr" rid="B33">Gunn et al., 2016</xref>). THC readily crosses the fetal-placental barrier (<xref ref-type="bibr" rid="B92">Wu et al., 2011</xref>) and is also secreted in breast milk (<xref ref-type="bibr" rid="B66">Perez-Reyes and Wall, 1982</xref>). As of now, there is no strong link between prenatal cannabis use and an increased risk of ASD in offspring. Prenatal exposure to cannabis does correlate with negative outcomes in child development, including growth restriction (<xref ref-type="bibr" rid="B97">Zuckerman et al., 1989</xref>; <xref ref-type="bibr" rid="B27">El Marroun et al., 2009</xref>; <xref ref-type="bibr" rid="B33">Gunn et al., 2016</xref>) and decreased cognitive performance (<xref ref-type="bibr" rid="B71">Richardson et al., 2002</xref>; <xref ref-type="bibr" rid="B32">Goldschmidt et al., 2004</xref>; <xref ref-type="bibr" rid="B33">Gunn et al., 2016</xref>). Still, few studies have been carried out on this topic and these observations are not always reproducible (<xref ref-type="bibr" rid="B92">Wu et al., 2011</xref>; <xref ref-type="bibr" rid="B26">El Marroun et al., 2018</xref>). Since rates of cannabis use in both pregnant and non-pregnant women are steadily increasing (<xref ref-type="bibr" rid="B12">Brown et al., 2017</xref>), there is an unmet need for clarifying the relationship between prenatal cannabis exposure and CNS development. Thus, future clinical and pre-clinical investigations should focus on elucidating the long-lasting effects of prenatal cannabis exposure and if these effects are linked to ASD pathogenesis. Such studies should be paired with efforts to determine if prenatal cannabis exposure impacts microglial synaptic pruning and thereby neurodevelopment in general. These experiments could also take place in the context of pathogen-induced MIA to better recapitulate environmental risks for ASD.</p>
</sec>
<sec id="S4.SS2">
<title>Cannabinoid Signaling as a Target for ASD Treatment</title>
<p>Pre-clinical evidence supporting the role of ECS signaling in ASD comes from research on rodent models of MIA and neuroinflammation. For instance, in response to the innate immunostimulant polyinosinic:polycytidylic acid [poly(I:C)], MIA-based production of IL-17 induces abnormal cortical development and ASD-like sociability deficits in mouse offspring (<xref ref-type="bibr" rid="B18">Choi et al., 2016</xref>). Interestingly, administration of AEA decreases IL-17 production and increases expression of the anti-inflammatory cytokine IL-10 in a mouse model of immune hypersensitivity (<xref ref-type="bibr" rid="B38">Jackson et al., 2014</xref>). Treatment with the innate immunostimulant lipopolysaccharide (LPS) during adolescence leads to increased AEA tone and FAAH activity in the amygdala, as well as decreased sociability, in mice (<xref ref-type="bibr" rid="B23">Doenni et al., 2016</xref>). These alterations are attenuated with administration of an FAAH inhibitor (<xref ref-type="bibr" rid="B23">Doenni et al., 2016</xref>). Still, the contribution of microglia to either the initiation or resolution of these neuroinflammatory effects is unknown and should be the focus of future endeavors.</p>
<p>Cannabidiol (CBD), the second major phytocannabinoid in cannabis (<xref ref-type="bibr" rid="B6">Atakan, 2012</xref>), has gained attention as a possible treatment for ASD (<xref ref-type="bibr" rid="B73">Salgado and Castellanos, 2018</xref>). Indeed, three clinical reports have recently established that CBD alleviates major symptoms associated with ASD, including seizures, sleeplessness, and anxiety, in children (<xref ref-type="bibr" rid="B8">Barchel et al., 2018</xref>; <xref ref-type="bibr" rid="B4">Aran et al., 2019</xref>; <xref ref-type="bibr" rid="B9">Bar-Lev Schleider et al., 2019</xref>). In addition, because CBD possess a weak affinity for CB<sub>1</sub> and CB<sub>2</sub>, it has no psychoactive effects and may even prevent some of the harmful consequences of THC (<xref ref-type="bibr" rid="B96">Zuardi et al., 2012</xref>; <xref ref-type="bibr" rid="B54">Morales et al., 2017</xref>; <xref ref-type="bibr" rid="B56">Mouro et al., 2019</xref>). Lastly, a commercially available, oral CBD extract (Epidiolex) has recently gained FDA-approval for treatment of drug-resistant epilepsy (<xref ref-type="bibr" rid="B78">Sekar and Pack, 2019</xref>), which can be an additional burden faced by ASD patients (<xref ref-type="bibr" rid="B75">Sansa et al., 2011</xref>; <xref ref-type="bibr" rid="B43">Kokoszka et al., 2017</xref>; <xref ref-type="bibr" rid="B48">Long et al., 2019</xref>). Nevertheless, because exposure to other cannabinoids negatively affects the development of the adolescent brain in rats (<xref ref-type="bibr" rid="B17">Cha et al., 2006</xref>; <xref ref-type="bibr" rid="B77">Schneider and Koch, 2007</xref>; <xref ref-type="bibr" rid="B68">Quinn et al., 2008</xref>), parents and physicians should practice extreme caution when recommending the use of cannabinoids to treat ASD (<xref ref-type="bibr" rid="B6">Atakan, 2012</xref>).</p>
<p>Subsequent work in this field must emphasize replicating the usefulness of ECS signaling in ASD via paradigms that include larger and more diverse populations. If these results hold, it will be important to establish if abatement of ASD symptoms is due to eCB signaling in microglia. For example, CBD blocks microglial activation (<xref ref-type="bibr" rid="B52">Martin-Moreno et al., 2011</xref>) and neuroinflammation (<xref ref-type="bibr" rid="B28">Elliott et al., 2018</xref>; <xref ref-type="bibr" rid="B51">Maroon and Bost, 2018</xref>), both of which are linked to seizure susceptibility (<xref ref-type="bibr" rid="B69">Rana and Musto, 2018</xref>; <xref ref-type="bibr" rid="B95">Zhao et al., 2018</xref>). Consequently, it will be beneficial to establish if CBD-based reduction of epilepsy in ASD patients is reliant on microglial-based mechanisms. Utilizing mice with microglia-specific loss of ECS components in combination with ASD-relevant mouse models could shed light on this area.</p>
</sec>
</sec>
<sec id="S5">
<title>Conclusion</title>
<p>Microglia are indispensable orchestrators of CNS development and homeostasis and are therefore likely involved in the pathogenesis of ASD. Microglial activity can be modulated by eCB signaling, which makes the ECS a potentially forceful tool in the prevention and management of CNS dysfunction. Future work must focus on detailing the mechanisms by which altered eCB signaling in microglia yields protective and detrimental effects in the CNS, particularly as it relates to the effects of chronic cannabis use. Answering these questions could provide improved therapeutics for ASD and its associated conditions.</p>
</sec>
<sec id="S6">
<title>Author Contributions</title>
<p>All authors wrote the manuscript. KT and DA designed the figure.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by a National Institutes of Health (NIH) postdoctoral training grant (T32AI100829-06A1 to DA) and an NIH research project grant (1R01HD092093 to KS).</p>
</fn>
</fn-group>
<ack>
<p>The authors would like to thank Dr. Marissa Co for providing invaluable comments in this manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alger</surname><given-names>B. E.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Supply and demand for endocannabinoids.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>34</volume>
<fpage>304</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2011.03.003</pub-id>
<pub-id pub-id-type="pmid">21507493</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alliot</surname><given-names>F.</given-names></name><name><surname>Godin</surname><given-names>I.</given-names></name><name><surname>Pessac</surname><given-names>B.</given-names></name></person-group> (<year>1999</year>). <article-title>Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain.</article-title>
<source/><italic>Brain Res. Dev. Brain Res.</italic>
<volume>117</volume>
<fpage>145</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/s0165-3806(99)00113-3</pub-id>
<pub-id pub-id-type="pmid">10567732</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="book"><collab>American Psychiatry Association</collab> (<year>2013</year>). <source/><italic>Diagnostic and Statistical Manual of Mental Disorders: DSM-5</italic>, <edition>5th Edn</edition>
<publisher-loc>Arlington, VA</publisher-loc>: <publisher-name>American Psychiatry Association</publisher-name>.</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aran</surname><given-names>A.</given-names></name><name><surname>Cassuto</surname><given-names>H.</given-names></name><name><surname>Lubotzky</surname><given-names>A.</given-names></name><name><surname>Wattad</surname><given-names>N.</given-names></name><name><surname>Hazan</surname><given-names>E.</given-names></name></person-group> (<year>2019</year>). <article-title>Brief report: cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems-a retrospective feasibility study.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>49</volume>
<fpage>1284</fpage>–<lpage>1288</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-018-3808-2</pub-id>
<pub-id pub-id-type="pmid">30382443</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Askew</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Olmos-Alonso</surname><given-names>A.</given-names></name><name><surname>Garcia-Moreno</surname><given-names>F.</given-names></name><name><surname>Liang</surname><given-names>Y.</given-names></name><name><surname>Richardson</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>18</volume>
<fpage>391</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.12.041</pub-id>
<pub-id pub-id-type="pmid">28076784</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atakan</surname><given-names>Z.</given-names></name></person-group> (<year>2012</year>). <article-title>Cannabis, a complex plant: different compounds and different effects on individuals.</article-title>
<source/><italic>Ther. Adv. Psychopharmacol.</italic>
<volume>2</volume>
<fpage>241</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1177/2045125312457586</pub-id>
<pub-id pub-id-type="pmid">23983983</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baio</surname><given-names>J.</given-names></name><name><surname>Wiggins</surname><given-names>L.</given-names></name><name><surname>Christensen</surname><given-names>D. L.</given-names></name><name><surname>Maenner</surname><given-names>M. J.</given-names></name><name><surname>Daniels</surname><given-names>J.</given-names></name><name><surname>Warren</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2014.</article-title>
<source/><italic>MMWR Surveill. Summ.</italic>
<volume>67</volume>
<fpage>1</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.ss6706a1</pub-id>
<pub-id pub-id-type="pmid">29701730</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barchel</surname><given-names>D.</given-names></name><name><surname>Stolar</surname><given-names>O.</given-names></name><name><surname>De-Haan</surname><given-names>T.</given-names></name><name><surname>Ziv-Baran</surname><given-names>T.</given-names></name><name><surname>Saban</surname><given-names>N.</given-names></name><name><surname>Fuchs</surname><given-names>D. O.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and Co-morbidities.</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>9</volume>:<issue>1521</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2018.01521</pub-id>
<pub-id pub-id-type="pmid">30687090</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Lev Schleider</surname><given-names>L.</given-names></name><name><surname>Mechoulam</surname><given-names>R.</given-names></name><name><surname>Saban</surname><given-names>N.</given-names></name><name><surname>Meiri</surname><given-names>G.</given-names></name><name><surname>Novack</surname><given-names>V.</given-names></name></person-group> (<year>2019</year>). <article-title>Real life experience of medical cannabis treatment in autism: analysis of safety and efficacy.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>9</volume>:<issue>200</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-37570-y</pub-id>
<pub-id pub-id-type="pmid">30655581</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benito</surname><given-names>C.</given-names></name><name><surname>Tolon</surname><given-names>R. M.</given-names></name><name><surname>Pazos</surname><given-names>M. R.</given-names></name><name><surname>Nunez</surname><given-names>E.</given-names></name><name><surname>Castillo</surname><given-names>A. I.</given-names></name><name><surname>Romero</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Cannabinoid CB2 receptors in human brain inflammation.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>153</volume>
<fpage>277</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="pmid">17934510</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bialas</surname><given-names>A. R.</given-names></name><name><surname>Stevens</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>TGF-beta signaling regulates neuronal C1q expression and developmental synaptic refinement.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>16</volume>
<fpage>1773</fpage>–<lpage>1782</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3560</pub-id>
<pub-id pub-id-type="pmid">24162655</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>Q. L.</given-names></name><name><surname>Sarvet</surname><given-names>A. L.</given-names></name><name><surname>Shmulewitz</surname><given-names>D.</given-names></name><name><surname>Martins</surname><given-names>S. S.</given-names></name><name><surname>Wall</surname><given-names>M. M.</given-names></name><name><surname>Hasin</surname><given-names>D. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002-2014.</article-title>
<source/><italic>JAMA</italic>
<volume>317</volume>
<fpage>207</fpage>–<lpage>209</lpage>.<pub-id pub-id-type="pmid">27992619</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruttger</surname><given-names>J.</given-names></name><name><surname>Karram</surname><given-names>K.</given-names></name><name><surname>Wortge</surname><given-names>S.</given-names></name><name><surname>Regen</surname><given-names>T.</given-names></name><name><surname>Marini</surname><given-names>F.</given-names></name><name><surname>Hoppmann</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system.</article-title>
<source/><italic>Immunity</italic>
<volume>43</volume>
<fpage>92</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.012</pub-id>
<pub-id pub-id-type="pmid">26163371</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butovsky</surname><given-names>O.</given-names></name><name><surname>Weiner</surname><given-names>H. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglial signatures and their role in health and disease.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>19</volume>
<fpage>622</fpage>–<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1038/s41583-018-0057-5</pub-id>
<pub-id pub-id-type="pmid">30206328</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Careaga</surname><given-names>M.</given-names></name><name><surname>Murai</surname><given-names>T.</given-names></name><name><surname>Bauman</surname><given-names>M. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>81</volume>
<fpage>391</fpage>–<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2016.10.020</pub-id>
<pub-id pub-id-type="pmid">28137374</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassano</surname><given-names>T.</given-names></name><name><surname>Calcagnini</surname><given-names>S.</given-names></name><name><surname>Pace</surname><given-names>L.</given-names></name><name><surname>De Marco</surname><given-names>F.</given-names></name><name><surname>Romano</surname><given-names>A.</given-names></name><name><surname>Gaetani</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>11</volume>:<issue>30</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00030</pub-id>
<pub-id pub-id-type="pmid">28210207</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>Y. M.</given-names></name><name><surname>White</surname><given-names>A. M.</given-names></name><name><surname>Kuhn</surname><given-names>C. M.</given-names></name><name><surname>Wilson</surname><given-names>W. A.</given-names></name><name><surname>Swartzwelder</surname><given-names>H. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Differential effects of delta9-THC on learning in adolescent and adult rats.</article-title>
<source/><italic>Pharmacol. Biochem. Behav.</italic>
<volume>83</volume>
<fpage>448</fpage>–<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2006.03.006</pub-id>
<pub-id pub-id-type="pmid">16631921</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>G. B.</given-names></name><name><surname>Yim</surname><given-names>Y. S.</given-names></name><name><surname>Wong</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S. V.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring.</article-title>
<source/><italic>Science</italic>
<volume>351</volume>
<fpage>933</fpage>–<lpage>939</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad0314</pub-id>
<pub-id pub-id-type="pmid">26822608</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comery</surname><given-names>T. A.</given-names></name><name><surname>Harris</surname><given-names>J. B.</given-names></name><name><surname>Willems</surname><given-names>P. J.</given-names></name><name><surname>Oostra</surname><given-names>B. A.</given-names></name><name><surname>Irwin</surname><given-names>S. A.</given-names></name><name><surname>Weiler</surname><given-names>I. J.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>94</volume>
<fpage>5401</fpage>–<lpage>5404</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.10.5401</pub-id>
<pub-id pub-id-type="pmid">9144249</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname><given-names>H. V.</given-names></name><name><surname>Freeman</surname><given-names>T. P.</given-names></name><name><surname>Mokrysz</surname><given-names>C.</given-names></name><name><surname>Lewis</surname><given-names>D. A.</given-names></name><name><surname>Morgan</surname><given-names>C. J.</given-names></name><name><surname>Parsons</surname><given-names>L. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Keep off the grass? Cannabis, cognition and addiction.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>17</volume>
<fpage>293</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.28</pub-id>
<pub-id pub-id-type="pmid">27052382</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhopeshwarkar</surname><given-names>A.</given-names></name><name><surname>Mackie</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>86</volume>
<fpage>430</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1124/mol.114.094649</pub-id>
<pub-id pub-id-type="pmid">25106425</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Marco</surname><given-names>B.</given-names></name><name><surname>Bonaccorso</surname><given-names>C. M.</given-names></name><name><surname>Aloisi</surname><given-names>E.</given-names></name><name><surname>D’Antoni</surname><given-names>S.</given-names></name><name><surname>Catania</surname><given-names>M. V.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuro-Inflammatory mechanisms in developmental disorders associated with intellectual disability and autism spectrum disorder: a neuro- immune perspective.</article-title>
<source/><italic>CNS Neurol. Disord. Drug Targets</italic>
<volume>15</volume>
<fpage>448</fpage>–<lpage>463</lpage>. <pub-id pub-id-type="doi">10.2174/1871527315666160321105039</pub-id>
<pub-id pub-id-type="pmid">26996174</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doenni</surname><given-names>V. M.</given-names></name><name><surname>Gray</surname><given-names>J. M.</given-names></name><name><surname>Song</surname><given-names>C. M.</given-names></name><name><surname>Patel</surname><given-names>S.</given-names></name><name><surname>Hill</surname><given-names>M. N.</given-names></name><name><surname>Pittman</surname><given-names>Q. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>58</volume>
<fpage>237</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.07.152</pub-id>
<pub-id pub-id-type="pmid">27453335</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donvito</surname><given-names>G.</given-names></name><name><surname>Nass</surname><given-names>S. R.</given-names></name><name><surname>Wilkerson</surname><given-names>J. L.</given-names></name><name><surname>Curry</surname><given-names>Z. A.</given-names></name><name><surname>Schurman</surname><given-names>L. D.</given-names></name><name><surname>Kinsey</surname><given-names>S. G.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>43</volume>
<fpage>52</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2017.204</pub-id>
<pub-id pub-id-type="pmid">28857069</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edmonson</surname><given-names>C. A.</given-names></name><name><surname>Ziats</surname><given-names>M. N.</given-names></name><name><surname>Rennert</surname><given-names>O. M.</given-names></name></person-group> (<year>2016</year>). <article-title>A non-inflammatory role for microglia in autism spectrum disorders.</article-title>
<source/><italic>Front. Neurol.</italic>
<volume>7</volume>:<issue>9</issue>. <pub-id pub-id-type="doi">10.3389/fneur.2016.00009</pub-id>
<pub-id pub-id-type="pmid">26869989</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Marroun</surname><given-names>H.</given-names></name><name><surname>Brown</surname><given-names>Q. L.</given-names></name><name><surname>Lund</surname><given-names>I. O.</given-names></name><name><surname>Coleman-Cowger</surname><given-names>V. H.</given-names></name><name><surname>Loree</surname><given-names>A. M.</given-names></name><name><surname>Chawla</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>An epidemiological, developmental and clinical overview of cannabis use during pregnancy.</article-title>
<source/><italic>Prev. Med.</italic>
<volume>116</volume>
<fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.ypmed.2018.08.036</pub-id>
<pub-id pub-id-type="pmid">30171964</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Marroun</surname><given-names>H.</given-names></name><name><surname>Tiemeier</surname><given-names>H.</given-names></name><name><surname>Steegers</surname><given-names>E. A.</given-names></name><name><surname>Jaddoe</surname><given-names>V. W.</given-names></name><name><surname>Hofman</surname><given-names>A.</given-names></name><name><surname>Verhulst</surname><given-names>F. C.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Intrauterine cannabis exposure affects fetal growth trajectories: the generation R study.</article-title>
<source/><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic>
<volume>48</volume>
<fpage>1173</fpage>–<lpage>1181</lpage>. <pub-id pub-id-type="doi">10.1097/CHI.0b013e3181bfa8ee</pub-id>
<pub-id pub-id-type="pmid">19858757</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>D. M.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name><name><surname>Nagarkatti</surname><given-names>M.</given-names></name><name><surname>Nagarkatti</surname><given-names>P. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Cannabidiol attenuates experimental autoimmune encephalomyelitis model of multiple sclerosis through induction of myeloid-derived suppressor cells.</article-title>
<source/><italic>Front. Immunol.</italic>
<volume>9</volume>:<issue>1782</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.01782</pub-id>
<pub-id pub-id-type="pmid">30123217</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fakhoury</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Autistic spectrum disorders: a review of clinical features, theories and diagnosis.</article-title>
<source/><italic>Int. J. Dev. Neurosci.</italic>
<volume>43</volume>
<fpage>70</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2015.04.003</pub-id>
<pub-id pub-id-type="pmid">25862937</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandal</surname><given-names>M. J.</given-names></name><name><surname>Haney</surname><given-names>J. R.</given-names></name><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Leppa</surname><given-names>V.</given-names></name><name><surname>Ramaswami</surname><given-names>G.</given-names></name><name><surname>Hartl</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap.</article-title>
<source/><italic>Science</italic>
<volume>359</volume>
<fpage>693</fpage>–<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad6469</pub-id>
<pub-id pub-id-type="pmid">29439242</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F.</given-names></name><name><surname>Greter</surname><given-names>M.</given-names></name><name><surname>Leboeuf</surname><given-names>M.</given-names></name><name><surname>Nandi</surname><given-names>S.</given-names></name><name><surname>See</surname><given-names>P.</given-names></name><name><surname>Gokhan</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Fate mapping analysis reveals that adult microglia derive from primitive macrophages.</article-title>
<source/><italic>Science</italic>
<volume>330</volume>
<fpage>841</fpage>–<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1126/science.1194637</pub-id>
<pub-id pub-id-type="pmid">20966214</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldschmidt</surname><given-names>L.</given-names></name><name><surname>Richardson</surname><given-names>G. A.</given-names></name><name><surname>Cornelius</surname><given-names>M. D.</given-names></name><name><surname>Day</surname><given-names>N. L.</given-names></name></person-group> (<year>2004</year>). <article-title>Prenatal marijuana and alcohol exposure and academic achievement at age 10.</article-title>
<source/><italic>Neurotoxicol. Teratol.</italic>
<volume>26</volume>
<fpage>521</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2004.04.003</pub-id>
<pub-id pub-id-type="pmid">15203174</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunn</surname><given-names>J. K.</given-names></name><name><surname>Rosales</surname><given-names>C. B.</given-names></name><name><surname>Center</surname><given-names>K. E.</given-names></name><name><surname>Nunez</surname><given-names>A.</given-names></name><name><surname>Gibson</surname><given-names>S. J.</given-names></name><name><surname>Christ</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis.</article-title>
<source/><italic>BMJ Open</italic>
<volume>6</volume>:<issue>e009986</issue>. <pub-id pub-id-type="doi">10.1136/bmjopen-2015-009986</pub-id>
<pub-id pub-id-type="pmid">27048634</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansel</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>Deregulation of synaptic plasticity in autism.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>688</volume>
<fpage>58</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2018.02.003</pub-id>
<pub-id pub-id-type="pmid">29421544</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Xiong</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>F.</given-names></name><name><surname>Qin</surname><given-names>G.</given-names></name><name><surname>Hu</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>21</volume>
<fpage>530</fpage>–<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0090-8</pub-id>
<pub-id pub-id-type="pmid">29472620</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutsler</surname><given-names>J. J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1309</volume>
<fpage>83</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.09.120</pub-id>
<pub-id pub-id-type="pmid">19896929</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilyasov</surname><given-names>A. A.</given-names></name><name><surname>Milligan</surname><given-names>C. E.</given-names></name><name><surname>Pharr</surname><given-names>E. P.</given-names></name><name><surname>Howlett</surname><given-names>A. C.</given-names></name></person-group> (<year>2018</year>). <article-title>The endocannabinoid system and oligodendrocytes in health and disease.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>12</volume>:<issue>733</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2018.00733</pub-id>
<pub-id pub-id-type="pmid">30416422</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>A. R.</given-names></name><name><surname>Nagarkatti</surname><given-names>P.</given-names></name><name><surname>Nagarkatti</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e93954</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0093954</pub-id>
<pub-id pub-id-type="pmid">24699635</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janda</surname><given-names>E.</given-names></name><name><surname>Boi</surname><given-names>L.</given-names></name><name><surname>Carta</surname><given-names>A. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglial phagocytosis and its regulation: a therapeutic target in Parkinson’s disease?</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>11</volume>:<issue>144</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00144</pub-id>
<pub-id pub-id-type="pmid">29755317</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H. Y.</given-names></name><name><surname>Xu</surname><given-names>L. L.</given-names></name><name><surname>Shao</surname><given-names>L.</given-names></name><name><surname>Xia</surname><given-names>R. M.</given-names></name><name><surname>Yu</surname><given-names>Z. H.</given-names></name><name><surname>Ling</surname><given-names>Z. X.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Maternal infection during pregnancy and risk of autism spectrum disorders: a systematic review and meta-analysis.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>58</volume>
<fpage>165</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.06.005</pub-id>
<pub-id pub-id-type="pmid">27287966</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kendall</surname><given-names>D. A.</given-names></name><name><surname>Yudowski</surname><given-names>G. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Cannabinoid receptors in the central nervous system: their signaling and roles in disease.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>10</volume>:<issue>294</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00294</pub-id>
<pub-id pub-id-type="pmid">28101004</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Cho</surname><given-names>M. H.</given-names></name><name><surname>Shim</surname><given-names>W. H.</given-names></name><name><surname>Kim</surname><given-names>J. K.</given-names></name><name><surname>Jeon</surname><given-names>E. Y.</given-names></name><name><surname>Kim</surname><given-names>D. H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>22</volume>
<fpage>1576</fpage>–<lpage>1584</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.103</pub-id>
<pub-id pub-id-type="pmid">27400854</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokoszka</surname><given-names>M. A.</given-names></name><name><surname>McGoldrick</surname><given-names>P. E.</given-names></name><name><surname>La Vega-Talbott</surname><given-names>M.</given-names></name><name><surname>Raynes</surname><given-names>H.</given-names></name><name><surname>Palmese</surname><given-names>C. A.</given-names></name><name><surname>Wolf</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Epilepsy surgery in patients with autism.</article-title>
<source/><italic>J. Neurosurg. Pediatr.</italic>
<volume>19</volume>
<fpage>196</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.3171/2016.7.PEDS1651</pub-id>
<pub-id pub-id-type="pmid">27885946</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leitner</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>The co-occurrence of autism and attention deficit hyperactivity disorder in children - what do we know?</article-title>
<source/><italic>Front. Hum. Neurosci.</italic>
<volume>8</volume>:<issue>268</issue>. <pub-id pub-id-type="doi">10.3389/fnhum.2014.00268</pub-id>
<pub-id pub-id-type="pmid">24808851</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenz</surname><given-names>K. M.</given-names></name><name><surname>Nelson</surname><given-names>L. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglia and beyond: innate immune cells as regulators of brain development and behavioral function.</article-title>
<source/><italic>Front. Immunol.</italic>
<volume>9</volume>:<issue>698</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00698</pub-id>
<pub-id pub-id-type="pmid">29706957</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lisboa</surname><given-names>S. F.</given-names></name><name><surname>Gomes</surname><given-names>F. V.</given-names></name><name><surname>Guimaraes</surname><given-names>F. S.</given-names></name><name><surname>Campos</surname><given-names>A. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Microglial cells as a link between cannabinoids and the immune hypothesis of psychiatric disorders.</article-title>
<source/><italic>Front. Neurol.</italic>
<volume>7</volume>:<issue>5</issue>. <pub-id pub-id-type="doi">10.3389/fneur.2016.00005</pub-id>
<pub-id pub-id-type="pmid">26858686</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombardi</surname><given-names>L. M.</given-names></name><name><surname>Baker</surname><given-names>S. A.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>MECP2 disorders: from the clinic to mice and back.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>125</volume>
<fpage>2914</fpage>–<lpage>2923</lpage>. <pub-id pub-id-type="doi">10.1172/JCI78167</pub-id>
<pub-id pub-id-type="pmid">26237041</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>The clinical and genetic features of co-occurring epilepsy and autism spectrum disorder in chinese children.</article-title>
<source/><italic>Front. Neurol.</italic>
<volume>10</volume>:<issue>505</issue>. <pub-id pub-id-type="doi">10.3389/fneur.2019.00505</pub-id>
<pub-id pub-id-type="pmid">31139143</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>B.</given-names></name><name><surname>Marsicano</surname><given-names>G.</given-names></name><name><surname>Maldonado</surname><given-names>R.</given-names></name><name><surname>Hillard</surname><given-names>C. J.</given-names></name></person-group> (<year>2015</year>). <article-title>The endocannabinoid system in guarding against fear, anxiety and stress.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>16</volume>
<fpage>705</fpage>–<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1038/nrn4036</pub-id>
<pub-id pub-id-type="pmid">26585799</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maezawa</surname><given-names>I.</given-names></name><name><surname>Jin</surname><given-names>L. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>5346</fpage>–<lpage>5356</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5966-09.2010</pub-id>
<pub-id pub-id-type="pmid">20392956</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maroon</surname><given-names>J.</given-names></name><name><surname>Bost</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Review of the neurological benefits of phytocannabinoids.</article-title>
<source/><italic>Surg. Neurol. Int.</italic>
<volume>9</volume>:<issue>91</issue>. <pub-id pub-id-type="doi">10.4103/sni.sni_45_18</pub-id>
<pub-id pub-id-type="pmid">29770251</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Moreno</surname><given-names>A. M.</given-names></name><name><surname>Reigada</surname><given-names>D.</given-names></name><name><surname>Ramirez</surname><given-names>B. G.</given-names></name><name><surname>Mechoulam</surname><given-names>R.</given-names></name><name><surname>Innamorato</surname><given-names>N.</given-names></name><name><surname>Cuadrado</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer’s disease.</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>79</volume>
<fpage>964</fpage>–<lpage>973</lpage>. <pub-id pub-id-type="doi">10.1124/mol.111.071290</pub-id>
<pub-id pub-id-type="pmid">21350020</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mecha</surname><given-names>M.</given-names></name><name><surname>Feliu</surname><given-names>A.</given-names></name><name><surname>Carrillo-Salinas</surname><given-names>F. J.</given-names></name><name><surname>Rueda-Zubiaurre</surname><given-names>A.</given-names></name><name><surname>Ortega-Gutierrez</surname><given-names>S.</given-names></name><name><surname>de Sola</surname><given-names>R. G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Endocannabinoids drive the acquisition of an alternative phenotype in microglia.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>49</volume>
<fpage>233</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2015.06.002</pub-id>
<pub-id pub-id-type="pmid">26086345</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>P.</given-names></name><name><surname>Hurst</surname><given-names>D. P.</given-names></name><name><surname>Reggio</surname><given-names>P. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Molecular targets of the phytocannabinoids: a complex picture.</article-title>
<source/><italic>Prog. Chem. Org. Nat. Prod.</italic>
<volume>103</volume>
<fpage>103</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-45541-9_4</pub-id>
<pub-id pub-id-type="pmid">28120232</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>J. T.</given-names></name><name><surname>Chana</surname><given-names>G.</given-names></name><name><surname>Pardo</surname><given-names>C. A.</given-names></name><name><surname>Achim</surname><given-names>C.</given-names></name><name><surname>Semendeferi</surname><given-names>K.</given-names></name><name><surname>Buckwalter</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>68</volume>
<fpage>368</fpage>–<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.05.024</pub-id>
<pub-id pub-id-type="pmid">20674603</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouro</surname><given-names>F. M.</given-names></name><name><surname>Miranda-Lourenco</surname><given-names>C.</given-names></name><name><surname>Sebastiao</surname><given-names>A. M.</given-names></name><name><surname>Diogenes</surname><given-names>M. J.</given-names></name></person-group> (<year>2019</year>). <article-title>From cannabinoids and neurosteroids to statins and the ketogenic diet: new therapeutic avenues in rett syndrome?</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>13</volume>:<issue>680</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2019.00680</pub-id>
<pub-id pub-id-type="pmid">31333401</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>N.</given-names></name><name><surname>Cowley</surname><given-names>T. R.</given-names></name><name><surname>Blau</surname><given-names>C. W.</given-names></name><name><surname>Dempsey</surname><given-names>C. N.</given-names></name><name><surname>Noonan</surname><given-names>J.</given-names></name><name><surname>Gowran</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>9</volume>:<issue>79</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-79</pub-id>
<pub-id pub-id-type="pmid">22537429</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>K.</given-names></name><name><surname>Honda</surname><given-names>S.</given-names></name><name><surname>Tohyama</surname><given-names>Y.</given-names></name><name><surname>Imai</surname><given-names>Y.</given-names></name><name><surname>Kohsaka</surname><given-names>S.</given-names></name><name><surname>Kurihara</surname><given-names>T.</given-names></name></person-group> (<year>2001</year>). <article-title>Neurotrophin secretion from cultured microglia.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>65</volume>
<fpage>322</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.1157</pub-id>
<pub-id pub-id-type="pmid">11494368</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palazuelos</surname><given-names>J.</given-names></name><name><surname>Aguado</surname><given-names>T.</given-names></name><name><surname>Pazos</surname><given-names>M. R.</given-names></name><name><surname>Julien</surname><given-names>B.</given-names></name><name><surname>Carrasco</surname><given-names>C.</given-names></name><name><surname>Resel</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Microglial CB2 cannabinoid receptors are neuroprotective in Huntington’s disease excitotoxicity.</article-title>
<source/><italic>Brain</italic>
<volume>132</volume>
<fpage>3152</fpage>–<lpage>3164</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awp239</pub-id>
<pub-id pub-id-type="pmid">19805493</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panagis</surname><given-names>G.</given-names></name><name><surname>Mackey</surname><given-names>B.</given-names></name><name><surname>Vlachou</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Cannabinoid regulation of brain reward processing with an emphasis on the role of CB1 receptors: a step back into the future.</article-title>
<source/><italic>Front. Psychiatry</italic>
<volume>5</volume>:<issue>92</issue>. <pub-id pub-id-type="doi">10.3389/fpsyt.2014.00092</pub-id>
<pub-id pub-id-type="pmid">25132823</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><name><surname>Maggi</surname><given-names>L.</given-names></name><name><surname>Scianni</surname><given-names>M.</given-names></name><name><surname>Panzanelli</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Synaptic pruning by microglia is necessary for normal brain development.</article-title>
<source/><italic>Science</italic>
<volume>333</volume>
<fpage>1456</fpage>–<lpage>1458</lpage>. <pub-id pub-id-type="doi">10.1126/science.1202529</pub-id>
<pub-id pub-id-type="pmid">21778362</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H. R.</given-names></name><name><surname>Lee</surname><given-names>J. M.</given-names></name><name><surname>Moon</surname><given-names>H. E.</given-names></name><name><surname>Lee</surname><given-names>D. S.</given-names></name><name><surname>Kim</surname><given-names>B. N.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>A short review on the current understanding of autism spectrum disorders.</article-title>
<source/><italic>Exp. Neurobiol.</italic>
<volume>25</volume>
<fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.5607/en.2016.25.1.1</pub-id>
<pub-id pub-id-type="pmid">26924928</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkhurst</surname><given-names>C. N.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Ninan</surname><given-names>I.</given-names></name><name><surname>Savas</surname><given-names>J. N.</given-names></name><name><surname>Yates</surname><given-names>J. R.</given-names><suffix>III</suffix></name><name><surname>Lafaille</surname><given-names>J. J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.</article-title>
<source/><italic>Cell</italic>
<volume>155</volume>
<fpage>1596</fpage>–<lpage>1609</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.11.030</pub-id>
<pub-id pub-id-type="pmid">24360280</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>L. H.</given-names></name><name><surname>Hurd</surname><given-names>Y. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Endocannabinoid signalling in reward and addiction.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>16</volume>
<fpage>579</fpage>–<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1038/nrn4004</pub-id>
<pub-id pub-id-type="pmid">26373473</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>P. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Maternal infection and immune involvement in autism.</article-title>
<source/><italic>Trends Mol. Med.</italic>
<volume>17</volume>
<fpage>389</fpage>–<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2011.03.001</pub-id>
<pub-id pub-id-type="pmid">21482187</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>M.</given-names></name><name><surname>Wall</surname><given-names>M. E.</given-names></name></person-group> (<year>1982</year>). <article-title>Presence of delta9-tetrahydrocannabinol in human milk.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>307</volume>
<fpage>819</fpage>–<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1056/nejm198209233071311</pub-id>
<pub-id pub-id-type="pmid">6287261</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postorino</surname><given-names>V.</given-names></name><name><surname>Fatta</surname><given-names>L. M.</given-names></name><name><surname>Sanges</surname><given-names>V.</given-names></name><name><surname>Giovagnoli</surname><given-names>G.</given-names></name><name><surname>De Peppo</surname><given-names>L.</given-names></name><name><surname>Vicari</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Intellectual disability in autism spectrum disorder: investigation of prevalence in an italian sample of children and adolescents.</article-title>
<source/><italic>Res. Dev. Disabil.</italic>
<volume>48</volume>
<fpage>193</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.ridd.2015.10.020</pub-id>
<pub-id pub-id-type="pmid">26619372</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>H. R.</given-names></name><name><surname>Matsumoto</surname><given-names>I.</given-names></name><name><surname>Callaghan</surname><given-names>P. D.</given-names></name><name><surname>Long</surname><given-names>L. E.</given-names></name><name><surname>Arnold</surname><given-names>J. C.</given-names></name><name><surname>Gunasekaran</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>33</volume>
<fpage>1113</fpage>–<lpage>1126</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1301475</pub-id>
<pub-id pub-id-type="pmid">17581536</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rana</surname><given-names>A.</given-names></name><name><surname>Musto</surname><given-names>A. E.</given-names></name></person-group> (<year>2018</year>). <article-title>The role of inflammation in the development of epilepsy.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>15</volume>:<issue>144</issue>. <pub-id pub-id-type="doi">10.1186/s12974-018-1192-7</pub-id>
<pub-id pub-id-type="pmid">29764485</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro Xavier</surname><given-names>A. L.</given-names></name><name><surname>Kress</surname><given-names>B. T.</given-names></name><name><surname>Goldman</surname><given-names>S. A.</given-names></name><name><surname>Lacerda de Menezes</surname><given-names>J. R.</given-names></name><name><surname>Nedergaard</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>A distinct population of microglia supports adult neurogenesis in the subventricular zone.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>35</volume>
<fpage>11848</fpage>–<lpage>11861</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1217-15.2015</pub-id>
<pub-id pub-id-type="pmid">26311768</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>G. A.</given-names></name><name><surname>Ryan</surname><given-names>C.</given-names></name><name><surname>Willford</surname><given-names>J.</given-names></name><name><surname>Day</surname><given-names>N. L.</given-names></name><name><surname>Goldschmidt</surname><given-names>L.</given-names></name></person-group> (<year>2002</year>). <article-title>Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years.</article-title>
<source/><italic>Neurotoxicol. Teratol.</italic>
<volume>24</volume>
<fpage>309</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1016/s0892-0362(02)00193-9</pub-id>
<pub-id pub-id-type="pmid">12009486</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saijo</surname><given-names>K.</given-names></name><name><surname>Glass</surname><given-names>C. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Microglial cell origin and phenotypes in health and disease.</article-title>
<source/><italic>Nat. Rev. Immunol.</italic>
<volume>11</volume>
<fpage>775</fpage>–<lpage>787</lpage>. <pub-id pub-id-type="doi">10.1038/nri3086</pub-id>
<pub-id pub-id-type="pmid">22025055</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salgado</surname><given-names>C. A.</given-names></name><name><surname>Castellanos</surname><given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Autism spectrum disorder and cannabidiol: have we seen this movie before?</article-title>
<source/><italic>Glob. Pediatr. Health</italic>
<volume>5</volume>:<issue>2333794X18815412</issue>.</mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salter</surname><given-names>M. W.</given-names></name><name><surname>Stevens</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Microglia emerge as central players in brain disease.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>23</volume>
<fpage>1018</fpage>–<lpage>1027</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4397</pub-id>
<pub-id pub-id-type="pmid">28886007</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sansa</surname><given-names>G.</given-names></name><name><surname>Carlson</surname><given-names>C.</given-names></name><name><surname>Doyle</surname><given-names>W.</given-names></name><name><surname>Weiner</surname><given-names>H. L.</given-names></name><name><surname>Bluvstein</surname><given-names>J.</given-names></name><name><surname>Barr</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Medically refractory epilepsy in autism.</article-title>
<source/><italic>Epilepsia</italic>
<volume>52</volume>
<fpage>1071</fpage>–<lpage>1075</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03069.x</pub-id>
<pub-id pub-id-type="pmid">21671922</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>D. P.</given-names></name><name><surname>Heller</surname><given-names>C. T.</given-names></name><name><surname>Gunner</surname><given-names>G.</given-names></name><name><surname>Heller</surname><given-names>M.</given-names></name><name><surname>Gordon</surname><given-names>C.</given-names></name><name><surname>Hammond</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Microglia contribute to circuit defects in Mecp2 null mice independent of microglia-specific loss of Mecp2 expression.</article-title>
<source/><italic>eLife</italic>
<volume>5</volume>:<issue>e15224</issue>. <pub-id pub-id-type="doi">10.7554/eLife.15224</pub-id>
<pub-id pub-id-type="pmid">27458802</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>M.</given-names></name><name><surname>Koch</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion.</article-title>
<source/><italic>Eur. Neuropsychopharmacol.</italic>
<volume>17</volume>
<fpage>180</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2006.03.009</pub-id>
<pub-id pub-id-type="pmid">16679004</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekar</surname><given-names>K.</given-names></name><name><surname>Pack</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects.</article-title>
<source/><italic>F1000Res</italic>
<volume>8</volume>:<issue>234</issue>. <pub-id pub-id-type="doi">10.12688/f1000research.16515.1</pub-id>
<pub-id pub-id-type="pmid">30854190</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Fatemi</surname><given-names>S. H.</given-names></name><name><surname>Sidwell</surname><given-names>R. W.</given-names></name><name><surname>Patterson</surname><given-names>P. H.</given-names></name></person-group> (<year>2003</year>). <article-title>Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>23</volume>
<fpage>297</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.23-01-00297.2003</pub-id>
<pub-id pub-id-type="pmid">12514227</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shigemoto-Mogami</surname><given-names>Y.</given-names></name><name><surname>Hoshikawa</surname><given-names>K.</given-names></name><name><surname>Goldman</surname><given-names>J. E.</given-names></name><name><surname>Sekino</surname><given-names>Y.</given-names></name><name><surname>Sato</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>2231</fpage>–<lpage>2243</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1619-13.2014</pub-id>
<pub-id pub-id-type="pmid">24501362</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra</surname><given-names>A.</given-names></name><name><surname>Encinas</surname><given-names>J. M.</given-names></name><name><surname>Deudero</surname><given-names>J. J.</given-names></name><name><surname>Chancey</surname><given-names>J. H.</given-names></name><name><surname>Enikolopov</surname><given-names>G.</given-names></name><name><surname>Overstreet-Wadiche</surname><given-names>L. S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>7</volume>
<fpage>483</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2010.08.014</pub-id>
<pub-id pub-id-type="pmid">20887954</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>B.</given-names></name><name><surname>Roque</surname><given-names>C. H.</given-names></name><name><surname>Hempstead</surname><given-names>B. L.</given-names></name><name><surname>Al-Ubaidi</surname><given-names>M. R.</given-names></name><name><surname>Roque</surname><given-names>R. S.</given-names></name></person-group> (<year>2004</year>). <article-title>Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>41839</fpage>–<lpage>41845</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m402872200</pub-id>
<pub-id pub-id-type="pmid">15277529</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A. K.</given-names></name><name><surname>Schwartz</surname><given-names>C. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>46</volume>(<issue>Pt 2</issue>), <fpage>161</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.02.015</pub-id>
<pub-id pub-id-type="pmid">24709068</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stella</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>Endocannabinoid signaling in microglial cells.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>56</volume>(<issue>Suppl. 1</issue>), <fpage>244</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.07.037</pub-id>
<pub-id pub-id-type="pmid">18722389</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>B.</given-names></name><name><surname>Allen</surname><given-names>N. J.</given-names></name><name><surname>Vazquez</surname><given-names>L. E.</given-names></name><name><surname>Howell</surname><given-names>G. R.</given-names></name><name><surname>Christopherson</surname><given-names>K. S.</given-names></name><name><surname>Nouri</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>The classical complement cascade mediates CNS synapse elimination.</article-title>
<source/><italic>Cell</italic>
<volume>131</volume>
<fpage>1164</fpage>–<lpage>1178</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.10.036</pub-id>
<pub-id pub-id-type="pmid">18083105</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Sugihara</surname><given-names>G.</given-names></name><name><surname>Ouchi</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name><name><surname>Futatsubashi</surname><given-names>M.</given-names></name><name><surname>Takebayashi</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Microglial activation in young adults with autism spectrum disorder.</article-title>
<source/><italic>JAMA Psychiatry</italic>
<volume>70</volume>
<fpage>49</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="pmid">23404112</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>G.</given-names></name><name><surname>Gudsnuk</surname><given-names>K.</given-names></name><name><surname>Kuo</surname><given-names>S. H.</given-names></name><name><surname>Cotrina</surname><given-names>M. L.</given-names></name><name><surname>Rosoklija</surname><given-names>G.</given-names></name><name><surname>Sosunov</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.</article-title>
<source/><italic>Neuron</italic>
<volume>83</volume>
<fpage>1131</fpage>–<lpage>1143</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.07.040</pub-id>
<pub-id pub-id-type="pmid">25155956</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>D. L.</given-names></name><name><surname>Nascimbene</surname><given-names>C.</given-names></name><name><surname>Krishnan</surname><given-names>C.</given-names></name><name><surname>Zimmerman</surname><given-names>A. W.</given-names></name><name><surname>Pardo</surname><given-names>C. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Neuroglial activation and neuroinflammation in the brain of patients with autism.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>57</volume>
<fpage>67</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20315</pub-id>
<pub-id pub-id-type="pmid">15546155</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voineagu</surname><given-names>I.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Johnston</surname><given-names>P.</given-names></name><name><surname>Lowe</surname><given-names>J. K.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Horvath</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology.</article-title>
<source/><italic>Nature</italic>
<volume>474</volume>
<fpage>380</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/nature10110</pub-id>
<pub-id pub-id-type="pmid">21614001</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Takumi</surname><given-names>T.</given-names></name><name><surname>Qiu</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Distinct defects in spine formation or pruning in two gene duplication mouse models of autism.</article-title>
<source/><italic>Neurosci. Bull.</italic>
<volume>33</volume>
<fpage>143</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-017-0111-8</pub-id>
<pub-id pub-id-type="pmid">28258509</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>Y.</given-names></name><name><surname>Boura-Halfon</surname><given-names>S.</given-names></name><name><surname>Cortese</surname><given-names>N.</given-names></name><name><surname>Haimon</surname><given-names>Z.</given-names></name><name><surname>Sar Shalom</surname><given-names>H.</given-names></name><name><surname>Kuperman</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Brown-adipose-tissue macrophages control tissue innervation and homeostatic energy expenditure.</article-title>
<source/><italic>Nat. Immunol.</italic>
<volume>18</volume>
<fpage>665</fpage>–<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3746</pub-id>
<pub-id pub-id-type="pmid">28459435</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C. S.</given-names></name><name><surname>Jew</surname><given-names>C. P.</given-names></name><name><surname>Lu</surname><given-names>H. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain.</article-title>
<source/><italic>Future Neurol.</italic>
<volume>6</volume>
<fpage>459</fpage>–<lpage>480</lpage>. <pub-id pub-id-type="doi">10.2217/fnl.11.27</pub-id>
<pub-id pub-id-type="pmid">22229018</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>I.</given-names></name><name><surname>Han</surname><given-names>S. J.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Crane</surname><given-names>C.</given-names></name><name><surname>Parsa</surname><given-names>A. T.</given-names></name></person-group> (<year>2010</year>). <article-title>The role of microglia in central nervous system immunity and glioma immunology.</article-title>
<source/><italic>J. Clin. Neurosci.</italic>
<volume>17</volume>
<fpage>6</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocn.2009.05.006</pub-id>
<pub-id pub-id-type="pmid">19926287</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>Y.</given-names></name><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Sforazzini</surname><given-names>F.</given-names></name><name><surname>Weinhard</surname><given-names>L.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>17</volume>
<fpage>400</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3641</pub-id>
<pub-id pub-id-type="pmid">24487234</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglial activation: an important process in the onset of epilepsy.</article-title>
<source/><italic>Am. J. Transl. Res.</italic>
<volume>10</volume>
<fpage>2877</fpage>–<lpage>2889</lpage>. <pub-id pub-id-type="pmid">30323874</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuardi</surname><given-names>A. W.</given-names></name><name><surname>Crippa</surname><given-names>J. A.</given-names></name><name><surname>Hallak</surname><given-names>J. E.</given-names></name><name><surname>Bhattacharyya</surname><given-names>S.</given-names></name><name><surname>Atakan</surname><given-names>Z.</given-names></name><name><surname>Martin-Santos</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>18</volume>
<fpage>5131</fpage>–<lpage>5140</lpage>. <pub-id pub-id-type="doi">10.2174/138161212802884681</pub-id>
<pub-id pub-id-type="pmid">22716160</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuckerman</surname><given-names>B.</given-names></name><name><surname>Frank</surname><given-names>D. A.</given-names></name><name><surname>Hingson</surname><given-names>R.</given-names></name><name><surname>Amaro</surname><given-names>H.</given-names></name><name><surname>Levenson</surname><given-names>S. M.</given-names></name><name><surname>Kayne</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>1989</year>). <article-title>Effects of maternal marijuana and cocaine use on fetal growth.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>320</volume>
<fpage>762</fpage>–<lpage>768</lpage>. <pub-id pub-id-type="doi">10.1056/nejm198903233201203</pub-id>
<pub-id pub-id-type="pmid">2784193</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>